News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,499 Results
Type
Article (42330)
Company Profile (294)
Press Release (672875)
Section
Business (210374)
Career Advice (2091)
Deals (36626)
Drug Delivery (106)
Drug Development (83016)
Employer Resources (175)
FDA (16547)
Job Trends (15395)
News (355904)
Policy (33880)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2590)
Accelerated approval (2)
Adcomms (21)
Allergies (84)
Alliances (51366)
ALS (85)
Alzheimer's disease (1364)
Antibody-drug conjugate (ADC) (115)
Approvals (16549)
Artificial intelligence (242)
Autoimmune disease (15)
Automation (14)
Bankruptcy (371)
Best Places to Work (11770)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (188)
Bladder cancer (56)
Brain cancer (26)
Breast cancer (248)
Cancer (2000)
Cardiovascular disease (161)
Career advice (1749)
Career pathing (30)
CAR-T (141)
Cell therapy (398)
Cervical cancer (17)
Clinical research (67213)
Collaboration (780)
Compensation (451)
Complete response letters (25)
COVID-19 (2652)
CRISPR (40)
C-suite (209)
Cystic fibrosis (101)
Data (1930)
Decentralized trials (2)
Denatured (26)
Depression (39)
Diabetes (250)
Diagnostics (6414)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (113)
Drug pricing (107)
Drug shortages (28)
Duchenne muscular dystrophy (85)
Earnings (87834)
Editorial (33)
Employer branding (21)
Employer resources (149)
Events (114455)
Executive appointments (642)
FDA (17661)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (693)
Gene editing (101)
Generative AI (20)
Gene therapy (288)
GLP-1 (716)
Government (4499)
Grass and pollen (4)
Guidances (48)
Healthcare (18986)
Huntington's disease (23)
IgA nephropathy (22)
Immunology and inflammation (112)
Indications (27)
Infectious disease (2781)
Inflammatory bowel disease (135)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (85)
Interviews (322)
IPO (16762)
IRA (47)
Job creations (4055)
Job search strategy (1492)
Kidney cancer (9)
Labor market (34)
Layoffs (471)
Leadership (16)
Legal (8367)
Liver cancer (71)
Lung cancer (290)
Lymphoma (131)
Machine learning (2)
Management (59)
Manufacturing (277)
MASH (62)
Medical device (13399)
Medtech (13404)
Mergers & acquisitions (20324)
Metabolic disorders (648)
Multiple sclerosis (68)
NASH (17)
Neurodegenerative disease (80)
Neuropsychiatric disorders (26)
Neuroscience (1844)
NextGen: Class of 2025 (6637)
Non-profit (4524)
Northern California (2403)
Now hiring (37)
Obesity (352)
Opinion (226)
Ovarian cancer (72)
Pain (85)
Pancreatic cancer (77)
Parkinson's disease (131)
Partnered (20)
Patents (206)
Patient recruitment (94)
Peanut (49)
People (59029)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20841)
Phase II (29574)
Phase III (22170)
Pipeline (983)
Podcasts (74)
Policy (119)
Postmarket research (2654)
Preclinical (8833)
Press Release (68)
Prostate cancer (93)
Psychedelics (31)
Radiopharmaceuticals (249)
Rare diseases (369)
Real estate (6251)
Recruiting (67)
Regulatory (22980)
Reports (46)
Research institute (2365)
Resumes & cover letters (358)
Rett syndrome (3)
RNA editing (3)
RSV (37)
Schizophrenia (70)
Series A (123)
Series B (78)
Service/supplier (12)
Sickle cell disease (52)
Southern California (2077)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (29)
Startups (3721)
State (2)
Stomach cancer (13)
Supply chain (60)
The Weekly (45)
United States (21116)
Vaccines (673)
Venture capitalists (37)
Webinars (12)
Weight loss (241)
Women's health (33)
Worklife (15)
Date
Today (81)
Last 7 days (609)
Last 30 days (2516)
Last 365 days (34070)
2025 (7839)
2024 (35770)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (780)
Alabama (49)
Alaska (7)
Arizona (230)
Arkansas (14)
Asia (40575)
Australia (6498)
California (5487)
Canada (1868)
China (480)
Colorado (247)
Connecticut (257)
Delaware (126)
Europe (86493)
Florida (812)
Georgia (190)
Idaho (57)
Illinois (502)
India (24)
Indiana (298)
Iowa (9)
Japan (144)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (833)
Massachusetts (4161)
Michigan (210)
Minnesota (368)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1568)
New Mexico (29)
New York (1571)
North Carolina (931)
North Dakota (7)
Northern California (2403)
Ohio (190)
Oklahoma (14)
Oregon (38)
Pennsylvania (1251)
Puerto Rico (9)
Rhode Island (26)
South America (1160)
South Carolina (18)
South Dakota (1)
Southern California (2077)
Tennessee (92)
Texas (822)
Utah (165)
Virginia (135)
Washington D.C. (57)
Washington State (514)
West Virginia (3)
Wisconsin (51)
715,499 Results for "adarx pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ADARx Pharmaceuticals to Present at the J.P. Morgan 43ʳᵈ Annual Healthcare Conference
January 10, 2025
·
1 min read
Business
ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer
ADARx Pharmaceuticals, Inc. today announced the appointment of Chris Storgard, M.D., as Chief Medical Officer (CMO).
April 2, 2024
·
3 min read
Biotech Beach
ADARx Pharmaceuticals to Participate in the 44th Annual Cowen Healthcare Conference
ADARx Pharmaceuticals, Inc. today announced that Zhen Li, PhD, Co-Founder, President and CEO, will host one-on-one investor meetings at the 44th Annual Cowen Healthcare Conference on Monday, March 4, 2024 in Boston, Massachusetts.
February 21, 2024
·
1 min read
Biotech Beach
ADARx Pharmaceuticals to Present at the J.P. Morgan 42nd Annual Healthcare Conference
ADARx Pharmaceuticals to Present at the J.P. Morgan 42nd Annual Healthcare Conference.
January 3, 2024
·
1 min read
Press Releases
ADARx Pharmaceuticals Appoints Ajim Tamboli, CFA as Chief Financial Officer
July 30, 2024
·
3 min read
Biotech Beach
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing.
August 9, 2023
·
3 min read
Biotech Beach
ADARx Pharmaceuticals Raises $46 Million as Lead Product Enters the Clinic
ADARx Pharmaceuticals, Inc., a clinical stage biotechnology company developing RNA-targeting therapeutics, today announced the close of a $46 million Series B-1 financing to advance its drug development pipeline as the Company’s first product enters the clinic.
January 20, 2023
·
2 min read
Drug Development
ADARx Pharmaceuticals Announces Dosing of First Cohort in Phase 1 Clinical Study of ADX-324
ADARx Pharmaceuticals, Inc., a clinical stage biotechnology company developing RNA-targeting therapeutics, today announced the dosing of the first cohort in a Phase 1 clinical study of ADX-324 for the treatment of hereditary angioedema (HAE).
January 20, 2023
·
2 min read
Business
ADARx Pharmaceuticals Expands Leadership Team, Appointing Robert MacLeod, Ph.D. as Chief Scientific Officer
ADARx Pharmaceuticals, Inc., a clinical stage biotechnology company developing RNA-targeting therapeutics, announced the expansion of their leadership team through the appointment of Robert MacLeod, Ph.D. as Chief Scientific Officer.
January 9, 2023
·
2 min read
Business
ADARx Pharmaceuticals Expands Leadership Team, Appointing Christopher Prentiss as CFO
ADARx Pharmaceuticals, Inc., a biotechnology company developing RNA-targeting therapeutics, announced the expansion of their leadership team through the appointment of Christopher Prentiss as Chief Financial Officer.
September 28, 2022
·
2 min read
1 of 71,550
Next
